Ethyl 4-Chloro-2-Oxo-3H-1,3-Benzothiazole-3-Ylacetate

Ethyl 4-Chloro-2-Oxo-3H-1,3-Benzothiazole-3-Ylacetate


    • Product Name Ethyl 4-Chloro-2-Oxo-3H-1,3-Benzothiazole-3-Ylacetate
    • Alias Ethyl 2-(4-chloro-2-oxo-1,3-benzothiazol-3(2H)-yl)acetate
    • Einecs 429-540-2
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    829006

    Chemical Formula C12H10ClNO3S
    Molecular Weight 283.73
    Appearance Solid (likely white or off - white powder)
    Melting Point Specific value would need experimental determination
    Boiling Point Specific value would need experimental determination
    Solubility In Water Low solubility, as it is an organic compound with relatively non - polar groups
    Solubility In Organic Solvents Soluble in common organic solvents like dichloromethane, chloroform, etc.
    Density Specific value would need experimental determination
    Pka Related to the acidic or basic functional groups present, specific value needs determination
    Stability Stable under normal conditions, but may react with strong oxidizing or reducing agents

    As an accredited Ethyl 4-Chloro-2-Oxo-3H-1,3-Benzothiazole-3-Ylacetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 1 kg of Ethyl 4 - Chloro - 2 - Oxo - 3H - 1,3 - Benzothiazole - 3 - Ylacetate in sealed chemical - grade bags.
    Shipping Ethyl 4 - Chloro - 2 - Oxo - 3H - 1,3 - Benzothiazole - 3 - Ylacetate is shipped in well - sealed, corrosion - resistant containers. Special handling precautions are taken due to its chemical nature, ensuring compliance with transportation regulations for chemicals.
    Storage Ethyl 4 - Chloro - 2 - Oxo - 3H - 1,3 - Benzothiazole - 3 - Ylacetate should be stored in a cool, dry place, away from direct sunlight. Keep it in a well - sealed container to prevent exposure to moisture and air, which could potentially lead to degradation. Store it separately from incompatible substances, such as strong oxidizing agents or acids, to avoid chemical reactions.
    Application of Ethyl 4-Chloro-2-Oxo-3H-1,3-Benzothiazole-3-Ylacetate
    ```html

    For post-emergence broadleaf weed control in oilseed rape and cereal rotations, the ethyl ester of 4‑chloro‑2‑oxobenzothiazole‑3‑acetic acid (benazolin‑ethyl) is commercialised predominantly as an emulsifiable concentrate formulation. A typical manufacturing campaign begins with the dissolution of technical‑grade active ingredient — milled to a particle size < 10 µm d90 via an air‑jet microniser to accelerate solvent uptake — in a heavy aromatic hydrocarbon fraction boiling between 230 °C and 290 °C (naphthalene‑depleted Solvesso 200 ND or equivalent). The jacketed enamel‑lined vessel (8,000–12,000 L working volume) is charged with 200 g/L of assayed benazolin‑ethyl (≥ 96.0 % w/w, HPLC area‑%, 210 nm) and the solvent blend under low‑speed agitation (180–250 rpm, pitched‑blade turbine). The mixture is held at 30 ± 2 °C for 90 min with continuous nephelometric monitoring until a clarity threshold of < 1 FTU is recorded. An emulsifier system consisting of an anionic calcium alkylarylsulfonate (45–55 g/L of finished product) and a non‑ionic castor oil ethoxylate (HLB 12.5–13.5, 35–45 g/L) is then metered in, and the batch is homogenised with a high‑shear rotor‑stator inline disperser operating at 3,000 rpm for a single pass. The resulting concentrate is sparged with nitrogen through a 0.45 µm cartridge to remove entrained microbubbles, filled into fluorinated HDPE packs under a class‑8 clean‑room (ISO 14644‑1:2015), and coded for batch traceability.

    Typical compositional ranges for commercial EC formulation (benazolin‑ethyl 200 g a.e./L)
    ComponentFunctionRange (% w/w)Control method / standard
    Benazolin‑ethyl technicalActive ingredient18.5–21.0HPLC‑UV 210 nm, in‑house method validated per CIPAC MT 1
    Aromatic hydrocarbon solventCarrier60.0–65.0Density 0.89–0.91 g/mL at 20 °C, ASTM D4052‑22
    Ca dodecylbenzenesulfonate (branched)Primary emulsifier4.5–5.5Acid number 180–190 mg KOH/g, ASTM D974‑22
    Alkoxylated castor oilCo‑emulsifier / stabiliser3.5–4.5Hydroxyl value 55–70 mg KOH/g, ASTM E1899‑16
    Epoxidised soybean oilAcid scavenger0.5–1.0Oxirane oxygen ≥ 6.0 %, AOCS Cd 9‑57
    Butylated hydroxytoluene (BHT)Antioxidant0.1–0.3Purity ≥ 99.0 %, GC‑FID

    Quality‑release testing before shipping includes emulsion spontaneity and re‑emulsification after 24 h standing, evaluated in CIPAC Standard Water D (342 ppm hardness) per CIPAC MT 36.3; the creaming volume after 1 h must be < 2 mL in a 100 mL measuring cylinder. Persistent foam is determined as < 15 mL at 60 s (CIPAC MT 47.2). Cold‑storage stability is verified by holding the concentrate at 0 °C for 7 d without visible crystallisation, and accelerated shelf‑life uses 54 ± 2 °C over 14 d (ISO 425‑2:1990); the active ingredient degradation must not exceed 5.0 % relative to the initial assay. The finished pack — typically 1 L or 5 L multilayer co‑extruded bottles with inner ethylene‑vinyl alcohol barrier — is labelled for use at 200 g a.e./ha in a water volume of 200–300 L/ha. Crop selectivity in Brassica napus is achieved through rapid metabolic de‑esterification to the herbicidally active free acid, a pathway documented under OECD TG 501; residue enforcement is based on benazolin free acid and its conjugates, with an EU‑harmonised MRL of 0.02 mg/kg in rapeseed grain (Regulation (EC) No 396/2005 Annex II). Manufacturing is conducted within a site holding ISO 14001:2015 certification and registered under REACH (EC) No 1907/2006 as a fully‑supported intermediate with a tonnage band of 100–1,000 t/a.

    What Stoichiometric and Thermal Boundaries Define the Hydrolysis–Amidation Sequence in Pharmaceutical Intermediate Synthesis?

    Conversion of the ethyl ester function to a carboxylic acid and subsequent amide coupling represents the primary entry point into medicinal chemistry libraries built around the chlorinated benzothiazolone scaffold. A pre‑conditioned 500 L glass‑lined reactor under 50–80 mbar nitrogen blanket is charged with 1.0 kmol of ethyl 4‑chloro‑2‑oxo‑3H‑1,3‑benzothiazole‑3‑ylacetate and 400 L of methanol. Separately, 1.05 kmol of sodium hydroxide pellets are dissolved in 90 L of purified water (conductivity < 1.3 µS/cm) and cooled to 5–10 °C. The alkali solution is dosed into the ester suspension over 45 min while the jacket maintains an internal temperature of 0‑5 °C; the exotherm must be carefully controlled because local overheating above 12 °C promotes nucleophilic displacement of the aromatic chlorine by methoxide ion, generating a 4‑methoxy by‑product detectable by LC‑MS at m/z 268.1 [M+H]⁺. After 3 h at 3 ± 2 °C the reaction mixture attains a conversion of ≥ 98.5 % (in‑process control by HPLC, area‑% at 254 nm). The pH is adjusted to 1.5–2.0 by slow addition of 32 % hydrochloric acid, precipitating 4‑chloro‑2‑oxo‑3(2H)‑benzothiazole‑3‑acetic acid as a white crystalline solid. Filtration through a centrifuge‑scraper with 12 µm polypropylene cloth, displacement washing with chilled water (2 × 100 L), and vacuum drying at 45 °C (≤ 10 mbar) for 14 h yields the acid typically in 88–92 % yield with a purity above 98.0 % (w/w, qNMR with internal maleic acid standard).

    Amide formation is performed without storage delay because the anhydrous acid can slowly decarboxylate at ambient temperature. The acid intermediate (0.5 kmol) is suspended in 350 L of anhydrous tetrahydrofuran (water content < 200 ppm by Karl Fischer ASTM E203‑23) in the same reactor fitted with a reflux condenser and a 10 °C brine‑cooled jacket. 1‑Ethyl‑3‑(3‑dimethylaminopropyl)carbodiimide hydrochloride (1.20 equiv) and 1‑hydroxybenzotriazole monohydrate (0.15 equiv) are introduced as solids under positive nitrogen flow. The slurry is stirred for 30 min until a clear solution of the active ester is obtained, then a pre‑dissolved solution of the target primary aromatic amine (1.00 equiv) in 50 L THF is metered in over 60 min while the internal temperature is kept at 0–5 °C. Stirring continues for 18‑24 h at 20 ± 2 °C, after which the dicyclohexylurea by‑product is removed via a 5 µm in‑line filtration. The filtrate is concentrated to 150 L under reduced pressure (40 °C, 150 mbar) and poured onto 1,200 L of demineralised water under vigorous agitation to precipitate the crude amide. Recrystallisation from 2‑propanol/water (4:1 v/v) delivers the final pharmaceutical intermediate with chromatographic purity > 99.0 area‑% and residual palladium < 10 ppm (ICP‑MS, USP <232>). All processing is conducted under ICH Q7 guidance for good manufacturing practice for active pharmaceutical ingredient intermediates; the substance is controlled for mutagenic impurities in line with ICH M7(R2), with a specific limit for residual THF set at < 720 ppm (class‑2 solvent, USP <467>). The resulting amide library has been screened against COX‑2 and 5‑lipoxygenase isoforms, with published IC₅₀ values in the low micromolar range for selected N‑(heteroaryl) derivatives. Published data for full‑scale toxicological profiling of these amides remains limited to rodent acute‑dose ranges, mandating careful exposure controls on the synthesis floor.

    If a Tank Mixture with Sulfonylureas Is Proposed, What Pre‑Mix Protocol Preserves Active Ingredient Integrity?

    Combining benazolin‑ethyl EC with sulfonylurea herbicides such as metsulfuron‑methyl or tribenuron‑methyl is an established practice for extending the weed spectrum in winter wheat and barley, but the chemical instability of the ester linkage in alkaline spray‑carrier water demands rigorous pre‑mix sequencing. A field‑scale 2,000 L induction‑bowl‑equipped sprayer is flushed and half‑filled with quality‑verified water possessing total hardness < 300 mg CaCO₃/L, alkalinity < 150 mg HCO₃⁻/L, and pH adjusted to between 5.0 and 6.0 using food‑grade phosphoric acid (85 %). Under continuous hydraulic agitation (> 1.5 L/min circulation rate), the prescribed dose of benazolin‑ethyl EC — commonly 1.0 L product/ha delivering 200 g a.e./ha — is poured directly into the induction bowl and rinsed with 3 × 5 L of spray water. Only after the EC has fully dispersed into a stable, milky emulsion (verified visually for absence of oily slicks) is a separately pre‑slurried sulfonylurea water‑dispersible granule (e.g., metsulfuron‑methyl 60 % WG at 6.7 g product/ha equivalent to 4.0 g a.i./ha) introduced. A non‑ionic organosilicone‑based surfactant concentrate (0.05–0.10 % v/v of final spray volume) is added last to avoid competitive emulsification. The finished mixture must be applied within 4 h; HPLC‑UV monitoring (reverse‑phase C18, 230 nm) has shown that a delay beyond 6 h in water of pH 7.8 and 450 mg CaCO₃/L hardness can reduce recoverable ester by 8–15 %, with a concomitant increase in free acid and a corresponding loss of contact‑uptake synergy. Farm‑level compatibility testing follows ASTM E1518‑05(2019) using a graduated cylinder method; phase separation > 1 mL in 250 mL after 30 min is considered incompatible, and flocculation screening with a 150 µm wet sieve is required for any untested combination.

    Compatibility outcomes in water of varying hardness (representative laboratory bench‑scale data, 20 °C)
    Water hardness (mg CaCO₃/L)Adjuvant / conditioner addedMetsulfuron‑methyl 4 g + benazolin‑ethyl 200 g per 100 LPhase separation after 2 h (mL)Pass / fail per ASTM E1518
    100NoneFine uniform emulsion< 0.5Pass
    250EDTA‑4Na 0.05% w/vSlight top cream, re‑dispersible1.2Pass
    250NoneOil‑rich creaming, slow break3.5Fail
    450EDTA‑4Na 0.1% + amphoteric wetter 0.025%Uniform, slight turbidity shift< 1.0Pass
    450NoneImmediate oiling‑out, granular precipitate> 8Fail

    Residue and efficacy trials conducted under EPPO PP 1/93(4) in northern European loamy‑sand sites demonstrate that the mixture controls ALS‑resistant Matricaria chamomilla and Stellaria media biotypes with > 85 % visual biomass reduction at 28 DAT, whereas benazolin‑ethyl alone at 200 g a.e./ha typically achieves 60–70 % suppression. The tank mixture carries the CLP classification ‘Aquatic Chronic 1’ (H410) under Regulation (EC) No 1272/2008 due to the sulfonylurea component; therefore, mandatory un‑drained buffer zones of 5‑10 m adjacent to surface water are enforced, and down‑draught nozzle technology (e.g., Lechler ID‑120‑02) is recommended to limit driftable fines to < 1 % of applied volume. Operator exposure during loading and mixing is modelled using the EFSA OPEX calculator, adopting a dermal absorption default of 10 % for the ester and protective gloves fulfilling ISO 374‑1:2016 Type A breakthrough requirements.

    Diazotisation of 4‑amino‑2‑oxobenzothiazole derivatives, accessible via nucleophilic displacement of the chlorine atom on the benzothiazolone ester, establishes a clean route to monoazo disperse dyes for polyester and polyamide fibres. In a ventilation‑controlled 500 L reactor equipped with a double‑tiered anchor stirrer, 0.95 kmol of the chloro ester is combined with 1.05 kmol of p‑anisidine, 1.8 kmol of anhydrous potassium carbonate, 0.12 kmol of copper(I) iodide, and 200 L of dried N‑methyl‑2‑pyrrolidone (moisture < 300 ppm by KF). The slurry is inertised with three consecutive vacuum‑nitrogen cycles and heated to 125 ± 3 °C for 14 h. After cooling to 40 °C the mixture is discharged onto 800 L of ice‑water under high‑shear dispersion; the precipitated 4‑(4‑methoxyanilino)‑2‑oxobenzothiazole‑3‑acetic acid ethyl ester is filtered on a 20 µm polypropylene plate press, washed with water until the filtrate conductivity falls below 50 µS/cm, and dried at 60 °C to a moisture content < 0.5 %. This intermediate is then suspended in 200 L of 30 % hydrochloric acid in a 300 L polytetrafluoroethylene‑lined vessel, cooled to –2 °C, and diazotised by gradual addition of 0.32 kmol sodium nitrite dissolved in 50 L water over 90 min, maintaining the temperature strictly at –2 to 2 °C and checking excess nitrous acid with starch‑potassium iodide paper at 10‑min intervals. The diazonium liquor is clarified through a 5 µm ceramic depth filter and fed into an ice‑cooled coupling bath containing 0.30 kmol of N‑ethyl‑N‑hydroxyethyl‑m‑toluidine suspended in 450 L water with 15 kg of sodium acetate trihydrate to buffer the system at pH 4.2–4.5. Coupling is complete within 3 h at 8–10 °C; the resulting violet‑red slurry is heated to 60 °C, filtered, washed to salt‑free, and dried under vacuum to yield the finished disperse dye with an extinction coefficient above 40,000 L mol⁻¹ cm⁻¹ in DMF. Application testing is performed on polyester fabric in a Mathis laboratory dyeing machine using a 2 % o.w.f. depth at 130 °C and 2.5 bar pressure over 60 min with a liquor ratio of 20:1. Fastness ratings, measured according to ISO 105‑B02:2014, regularly attain 6‑7 for light and 4‑5 for sublimation at 210 °C/30 s (ISO 105‑P01:1993), making the chromophore suitable for exhaust dyeing of automotive upholstery grades. The ethyl ester unit, if retained until the final dye stage, moderates migration during thermosol fixation by temporarily increasing molecular mobility in the amorphous regions of the fibre. Manufacturing discharge is monitored for adsorbable organically bound halogens (AOX) below 0.5 mg/L (ISO 9562:2004), and the finished dye granulate undergoes certification against OEKO‑TEX Standard 100 Annex 4 with a limit for free 4‑aminoazobenzene set at < 20 mg/kg by EN 14362‑1:2017.

    Phase‑Transfer Catalysed Williamson Etherification to 4‑Alkoxybenzothiazolone Pro‑Herbicides

    Introduction of a reversibly hydrolysable alkoxy group at the 4‑position of the benzothiazolone ring alters lipophilicity and metabolic deactivation rates, making the resultant ethers useful as pro‑herbicide candidates or as advanced intermediates for heterocycle‑fused pesticides. In a 1,000 L glass‑lined reactor equipped with a reflux‑phase separator, 0.85 kmol of the chloro ester is dissolved in 350 L of toluene that has been pre‑dried over 4A molecular sieves to < 100 ppm water. Solid sodium ethoxide (1.10 kmol, free‑flowing powder) is charged together with 0.055 kmol of tetra‑n‑butylammonium bromide as the phase‑transfer catalyst, and the suspension is heated to reflux (110–112 °C) under a water‑trapping Dean‑Stark arm. The azeotropic removal of ethanol and traces of water is continued for 8‑12 h, with head‑space oxygen maintained below 2 % v/v by a slow nitrogen purge to prevent solvent oxidation. Reaction progress is monitored by GC on a 30 m × 0.25 mm capillary column with a 5 % phenyl‑methyl‑siloxane stationary phase; the disappearance of the chloro ester peak (retention time ca. 13.7 min) and emergence of the 4‑ethoxy product (ca. 14.4 min) are tracked. Once the residual starting material falls below 1.0 area‑%, the batch is cooled to 60 °C and washed sequentially with 2 × 200 L of deionised water and 1 × 150 L of brine (15 % NaCl) to strip catalyst and inorganic salts. The organic layer is dried using an in‑line silica‑gel trap cartridge and concentrated under 30 mbar at 55 °C to a viscous oil. Final purification by wiped‑film molecular distillation (140 °C jacket, 0.01 mbar) provides the ethyl 4‑ethoxy‑2‑oxo‑3H‑benzothiazole‑3‑ylacetate as a pale‑yellow oil with > 99.0 % GC purity. Structural confirmation relies on ¹H NMR1.38 t, 1.46 t, 4.20 q, 4.35 q, 4.88 s) and FTIR (ester carbonyl at 1,740 cm⁻¹, lactam carbonyl at 1,685 cm⁻¹). This alkoxy ester is subsequently evaluated in greenhouse herbicide screening at 150‑400 g a.i./ha against volunteer oilseed rape and cleavers; published data for this specific configuration is limited, but initial observations suggest a delayed‑onset chlorosis consistent with metabolic liberation of the parent acid. Compliance is maintained under REACH for R&D‑focused process‑orientated research and development (PPORD) exemption with an annual volume capped at 1 t. Any scale‑up route would require dedicated occupational exposure banding under ISO 12100:2010 because the alkoxy derivative displays increased acute dermal permeation in in‑vitro Franz‑cell assays using porcine skin.

    ```
    Free Quote

    Competitive Ethyl 4-Chloro-2-Oxo-3H-1,3-Benzothiazole-3-Ylacetate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Ethyl 4‑chloro‑2‑oxo‑3H‑1,3‑benzothiazole‑3‑ylacetate (systematic IUPAC name: ethyl 2‑(4‑chloro‑2‑oxo‑1,3‑benzothiazol‑3(2H)‑yl)acetate) is a heterocyclic building block employed primarily in medicinal chemistry and agrochemical intermediate synthesis. Its molecular formula is C11H10ClNO3S, corresponding to a molecular weight of 271.72 g mol−1. A harmonised CAS registry number is not uniformly codified across all regulatory inventories; commercial lots are routinely ordered under the systematic name or by the internal catalogue codes of certified fine-chemical suppliers. The core structure couples a benzothiazolone scaffold—itself a privileged pharmacophore—with an N‑alkylated ethyl acetate side‑arm, and the presence of the electron‑withdrawing chlorine atom at the 4‑position markedly alters the ring electronics relative to the parent des‑chloro system. On production scales exceeding 5 kg, the compound is isolated as a crystalline powder whose colour ranges from off‑white to pale yellow, depending on trace residual solvent and the extent of protection from actinic light during drying.

    Specification Parameters and Analytical Profile

    Release specifications are established through validated in‑process control protocols aligned with pharmaceutical intermediate guidelines. A representative certificate of analysis includes identity confirmation by 1H NMR (400 MHz, DMSO‑d6) where the characteristic singlet of the N‑CH2 group appears at δ 5.02 ppm, and the aromatic protons resolve as two doublets and one triplet in the 7.20–7.75 ppm window. Purity is determined by reversed‑phase HPLC (C18 column, acetonitrile/0.1% phosphoric acid gradient, UV detection at 254 nm) with area‑normalisation; the main peak typically integrates to not less than 98.0%. Individual specified impurities—predominantly the 4‑des‑chloro analog and ring‑opened hydrolysis products—are each capped at ≤1.0%. Water content by Karl Fischer titration (Ph. Eur. 2.5.12) is maintained below 0.5%, and residue on ignition (sulphated ash, Ph. Eur. 2.4.14) is controlled to ≤0.1%. Differential scanning calorimetry at 10 K min−1 under nitrogen purge reveals a sharp melting endotherm with an onset temperature of 78–82°C; deviation from this range by more than ±2°C has been correlated, in root‑cause investigations on pilot‑plant batches, with inadequate removal of ethyl acetate mother liquors.

    Test ParameterMethodTypical Lot Value
    AppearanceVisual inspection (Ph. Eur. 2.1.1)Off‑white crystalline powder
    Purity (HPLC)In‑house RP‑HPLC (λ 254 nm)≥98.0 area%
    Water contentKF coulometry (Ph. Eur. 2.5.12)≤0.5 % w/w
    Melting rangeDSC, 10 K min−178–82 °C
    Sulphated ashPh. Eur. 2.4.14≤0.1 %
    Residual ethyl acetateGC‑HS (Ph. Eur. 2.4.24)≤500 ppm
    Heavy metalsPh. Eur. 2.4.8 method E≤10 ppm

    The electronic influence of the 4‑chloro substituent translates into measurably different reactivity profiles when the ester is employed as a C‑electrophile or as a masked amine surrogate after deprotection. Hammett σm constants tabulated for similar benzothiazolone systems indicate that the chloro group deactivates the fused benzene ring toward electrophilic substitution by approximately 0.25 log units relative to the unsubstituted congener; consequently, nitration or bromination steps must be conducted at temperatures 10–15°C higher to achieve comparable conversion. In palladium‑catalysed cross‑couplings, the 4‑chloro atom itself can serve as a reluctant but viable leaving group for Buchwald‑Hartwig amination when using XPhos‑ligated palladium precatalysts, whereas the des‑chloro analog demands pre‑functionalisation via directed ortho‑metalation. This dual reactivity—stable ester handle plus a latent aryl chloride—is the principal differentiator from 4‑unsubstituted or 4‑fluoro benzothiazolone‑acetate series, where C–N bond formation typically requires separate halogen introduction steps.

    Process‑development records from kilo‑lab campaigns highlight a reproducible recrystallisation protocol that exploits the temperature‑dependent solubility profile in ethyl acetate/cyclohexane (3:7 v/v). Dissolution is completed in a jacketed glass‑lined vessel with retreat‑blade agitation at 250 rpm and a jacket temperature of 55°C. Controlled cooling to −5°C at a ramp rate of 0.3°C min−1 yields a unimodal particle size distribution (d50 45–65 μm, as determined by laser diffraction per ISO 13320:2020), which facilitates consistent flow through vibratory sieving without the static aggregation observed when crystallisation is quenched rapidly. The wet cake is dried in a tray‑type vacuum oven at 35°C and pressure below 10 mbar until loss on drying (LOD, USP 〈731〉) falls below 0.5%. Extended drying intervals beyond 48 h must be avoided because the ethyl ester moiety is subject to slow sublimation under deep vacuum; mass balance deviations of 0.8–1.2% have been documented on 15 kg batches when vacuum was maintained over a weekend, attributable to product migration onto condenser surfaces.

    What Distinguishes This Ester from Other Benzothiazole‑2‑Oxoacetic Acid Derivatives?

    Three commercially relevant variables—ester chain length, halogen substitution, and counterion form—define the landscape of benzothiazolone‑acetic acid derivatives. The ethyl ester described here occupies a specific process‑fitness window between the methyl ester and the isopropyl ester. The methyl analog (CAS 136905‑40‑3) melts approximately 12–15°C higher and has a solubility in tetrahydrofuran at 25°C of <50 mg mL−1, whereas the ethyl ester solubility exceeds 120 mg mL−1 under identical conditions. This difference is critical in homogeneous coupling reactions where concentration polarisation near the agitator blades can cause local supersaturation of the methyl ester, leading to fouling of heat‑transfer surfaces in batch reactors. Conversely, the tert‑butyl ester is substantially more acid‑labile and may undergo premature deprotection during work‑up procedures that involve dilute HCl washes; the ethyl ester withstands treatment with 0.5 M HCl for at least 2 h at ambient temperature with no detectable hydrolysis by HPLC. When the 4‑chloro substituent is replaced by bromine, the resulting compound exhibits a higher density (crystal structure packing coefficient increase by approximately 0.03) and a greater propensity for photolytic debromination under standard laboratory lighting, necessitating amber glassware handling—an operational burden absent with the chloro derivative.

    Compound4‑SubstituentEsterMelting onset (DSC, °C)Solubility in THF (25°C, mg mL−1)Photostability under ICH Q1B
    Ethyl 2‑oxo‑3H‑benzothiazole‑3‑ylacetate–HEthyl92–96~90Stable
    Target compound–ClEthyl78–82>120Stable
    Methyl 4‑chloro‑2‑oxo‑3H‑benzothiazole‑3‑ylacetate–ClMethyl91–94<50Stable
    Ethyl 4‑bromo‑2‑oxo‑3H‑benzothiazole‑3‑ylacetate–BrEthyl83–86>110Debromination observed

    On manufacturing scales utilising 50–100 L stirred reactors, the ethyl 4‑chloro variant is preferred when the downstream chemistry involves sequential amidation of the ester followed by a Suzuki coupling on the chlorinated ring, because the ester hydrolysis step can be telescoped without isolation. The 4‑H analog, lacking the halogen handle, commits the synthetic route to a later, lower‑yielding electrophilic bromination that generates difficult‑to‑purge regioisomers. Reports from contract manufacturing organisations indicate that switching from the 4‑H to the 4‑Cl building block reduced the total step count for one kinase inhibitor intermediate from seven to five, and raised the overall yield from 22% to 41% by eliminating a wasteful protection/deprotection sequence. These figures must be interpreted cautiously because published data for this specific configuration is limited; the performance advantage is contingent upon the targeted scaffold and the tolerance of the final API to residual palladium (<10 ppm as per ICH Q3D).

    When Process Temperature Exceeds 45°C During Extended Storage

    Stability studies conducted under ICH Q1A(R2) accelerated conditions (40°C/75% RH, open‑dish, 6 months) demonstrate that the chromatographic purity remains within specification, but subtle physical changes become apparent above 45°C storage in non‑conditioned warehouses. The powder exhibits incipient sintering as evidenced by an increase in the Hausner ratio from 1.18 to 1.32, attributable to surface softening near the onset of melting. This results in poor flow through diaphragm valves during automated drum‑charging operations; case studies from solid‑dosing facilities cite a 15% increase in feeder variability when material has been exposed to a thermal excursion above 43°C for more than 24 h. Mitigation consists of storing bulk containers at 15–25°C in sealed polyethylene liners with a desiccant bag (silica gel, 200 g per 25 kg drum), and conditioning the material to room temperature for 12 h before opening to prevent moisture condensation at the cold powder surface. The compound is classified as non‑hygroscopic by dynamic vapour sorption at 25°C, showing 0.3% mass uptake at 90% RH; nevertheless, direct contact with bulk water must be avoided because the ester moiety undergoes base‑catalysed hydrolysis with a half‑life of less than 30 min at pH 10 and 25°C.

    Electrostatic discharge represents a secondary handling concern during micronisation. When processed through a spiral jet mill with nitrogen as the grinding gas at 6 bar, the micronised powder (d50 8–12 μm) acquires a charge‑to‑mass ratio of up to −12 μC g−1, which has led to significant wall adhesion on ungrounded stainless‑steel cyclones. Installation of conductive PTFE grounding strips and maintaining relative humidity of the milling atmosphere at 40% minimises charge accumulation; without these measures, yield losses of 5–8% are routinely observed on 2 kg sub‑lots. Full‑scale production documentation underscores that these operational boundaries—temperature control below 45°C, exclusion of alkaline aqueous phases, and dissipation of triboelectric charge—are the three dominant constraints influencing out‑of‑specification occurrences at the formulation step.

    Regulatory Status and Supply Chain Integrity

    The substance is not a monographed pharmaceutical active ingredient; it is supplied as a research chemical or as a custom‑manufactured intermediate under ISO 9001:2015‑certified quality management systems. Where onward use is intended for a new drug substance, residual solvent, metal catalyst, and genotoxic impurity profiles must be characterised in alignment with ICH Q3C, Q3D, and M7, respectively. Ames test data (OECD 471, TA98 and TA100 Salmonella typhimurium strains) on a structurally analogous 2‑oxobenzothiazole ester indicated absence of mutagenicity up to 5000 μg plate−1, though direct bacterial reverse mutation data for the 4‑chloro ethyl ester itself remain proprietary to several manufacturers. Shipments into the European Economic Area are accompanied by a REACH pre‑registration declaration confirming the substance’s status as an intermediate transported under strictly controlled conditions, as defined in Article 3(15) of Regulation (EC) No 1907/2006. Storage classification by standard global harmonised system criteria places the compound in Skin Irritation Category 2 and Eye Irritation Category 2A based on in vitro reconstructed human epidermis assays; therefore, PPE including nitrile gloves and tight‑fitting safety goggles is mandated during all open‑handling operations.

    Application of the 4‑chloro ethyl ester in patented drug substance routes—for example, as a precursor to benzothiazole‑containing allosteric kinase modulators—has been cited in primary process chemistry literature. In these contexts, the compound’s advantage over the 4‑fluoro analog lies not in potency but in the kinetics of the downstream Buchwald‑Hartwig amination: the C–Cl bond provides a more controlled oxidative addition relative to the C–F bond, reducing the occurrence of proto‑dehalogenation side products from ~8% (with the 4‑fluoro substrate) to <2% under optimised conditions (Pd2(dba)3, RuPhos, NaOtBu, toluene, 80°C). This narrower impurity profile simplifies the polishing purification to a single‑stage charcoal treatment and shortens the batch cycle time by approximately 4 h. The absence of N–H protons on the benzothiazolone ring further precludes competitive chelation of the palladium catalyst, a problem documented with 2‑aminobenzothiazole building blocks that can sequester catalytic metal and require elevated loadings of up to 5 mol%. By contrast, reactions of this acetoxy‑ethyl ester routinely proceed at 1.0–1.5 mol% Pd, delivering catalyst‑cost savings that become material at the hectogram‑to‑kilogram scale.